Journal List > Infect Chemother > v.41(4) > 1075471

Hong, Yoo, Kim, Mo, Ahn, Jeong, Kim, Lee, Jung, and Yoon: A Case of Multidrug-resistant Acinetobacter baumannii Ventriculitis Successfully Treated with Intrathecal Colistimethate

Abstract

Acinetobacter species is a non-fermentative aerobic gram-negative coccobacillus that is an important pathogen found in nosocomial infections. Recently, multi-drug resistant Acinetobacter baumannii (MDR-AB) infections have been increasing and pose a serious problem. Most such infections present as bacteremia, pneumonia, or a wound infection; however, CNS infections are very rare. We herein present a case of ventriculitis caused by MDR-AB in a 37-year old man after a neurosurgical intervention. The patient was successfully treated with intrathecal colistimethate.

Figures and Tables

Fig. 1
Gram stain on CSF showed numerous gram negative cocobacilli that were identified as Acinetobacter baumannii (Cerebrospinal fluid, H&E stain, ×1,000).
ic-41-240-g001
Table 1
Summary of Antibiotic Treatment and Laboratory Data in a Patient with Multidrug-resistant Acinetobacter baumannii Ventriculitis
ic-41-240-i001

Abbreviations: CSF, cerebrospinal fluid; PMN, polymorphonuclear cells; Lym, lymphocytes; IV, intravenous

References

1. Bergogne-Bérézin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev. 1996. 9:148–165.
crossref
2. Blot S, Vandewoude K, Colardyn F. Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study. Intensive Care Med. 2003. 29:471–475.
crossref
3. Jawad A, Heritage J, Snelling AM, Gascoyne-Binzi DM, Hawkey PM. Influence of relative humidity and suspending menstrua on survival of Acinetobacter spp. on dry surfaces. J Clin Microbiol. 1996. 34:2881–2887.
crossref
4. Fournier PE, Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis. 2006. 42:692–699.
crossref
5. Fernandez-Viladrich P, Corbella X, Corral L, Tubau F, Mateu A. Successful treatment of ventriculitis due to carbapenem-resistant Acinetobacter baumannii with intraventricular colistin sulfomethate sodium. Clin Infect Dis. 1999. 28:916–917.
crossref
6. Vasen W, Desmery P, Ilutovich S, Di Martino A. Intrathecal use of colistin. J Clin Microbiol. 2000. 38:3523.
crossref
7. Ho YH, Wang LS, Chao HJ, Chang KC, Su CF. Successful treatment of meningitis caused by multidrug-resistant Acinetobacter baumannii with intravenous and intrathecal colistin. J Micobiol Immunol Infect. 2007. 40:537–540.
8. Katragkou A, Roilides E. Successful treatment of multidrug resistant Acinetobacter baumannii central nervous system infections with colistin. J Clin Microbiol. 2005. 43:4916–4917.
crossref
9. Ng J, Gosbell IB, Kelly JA, Boyle MJ, Ferguson JK. Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature review. J Antimicrob Chemother. 2006. 58:1078–1081.
crossref
10. Seifert H, Richter W, Pulverer G. Clinical and bacteriological features of relapsing shunt-associated meningitis due to Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis. 1995. 14:130–134.
crossref
11. Bonomo RA, Szabo D. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin Infect Dis. 2006. 43:Suppl 2. 49–56.
12. Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis. 2005. 40:1333–1341.
crossref
13. Benedict RG, Langlykke AF. Antibiotic activity of Bacillus polymyxa. J Bacteriol. 1947. 54:24–25.
14. Wang KW, Chang WN, Huang CR, Tsai NW, Tsui HW, Wang HC, Su TM, Rau CS, Cheng BC, Chang CS, Chuang YC, Liliang PC, Tsai YD, Lu CH. Post-neurosurgical nosocomial bacterial meningitis in adults: microbiology, clinical features, and outcomes. J Clin Neurosci. 2005. 12:647–650.
crossref
15. Kunin CM, Bugg A. Binding of polymyxin antibiotics to tissues: the major determinant of distribution and persistence in the body. J Infect Dis. 1971. 124:394–400.
crossref
16. Craig WA, Kunin CM. Significance of serum protein and tissue binding of antimicrobial agents. Ann Rev Med. 1976. 27:287–300.
crossref
17. Jiménez-Mejías ME, Pichardo-Guerrero C, Máquez-Rivas FJ, Martín-Lozano D, Prados T, Pachón J. Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis. Eur J Clin Microbiol Infect Dis. 2002. 21:212–214.
crossref
TOOLS
Similar articles